ArticleOncotarget2017

Novel proteasome inhibitor delanzomib sensitizes cervical cancer cells to doxorubicin-induced apoptosis via stabilizing tumor suppressor proteins in the p53 pathway.

Kevin Y Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.